KMTS
Kestra Medical Technologies
NASDAQ · Health Care
$25.47
+0.35 (+1.39%)
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 70.46M | 467.86M | 451.21M | 384.70M |
| Net Income | -134,068,629 | 61.58M | 72.02M | 57.24M |
| EPS | — | — | — | — |
| Profit Margin | -190.3% | 13.2% | 16.0% | 14.9% |
| Rev Growth | — | +24.3% | -1.3% | +10.4% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 123.90M | 164.83M | 164.09M | 153.25M |
| Total Equity | 619.18M | 1.08B | 950.20M | 957.14M |
| D/E Ratio | 0.20 | 0.15 | 0.17 | 0.16 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | -119,183,785 | 118.92M | 127.55M | 105.65M |
| Free Cash Flow | — | 46.82M | 46.49M | 55.42M |